본문 바로가기
bar_progress

Text Size

Close

Cellid Submits Application for COVID-19 Vaccine Phase 2b Clinical Trial to MFDS

[Asia Economy Reporter Ji Yeon-jin] Cellid announced on the 12th that it has submitted a clinical trial plan for Phase 2b/3 of the COVID-19 preventive vaccine (AdCLD-CoV19-1) to the Ministry of Food and Drug Safety.


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top